{"product_id":"hcm-131","title":"Anti-Hepatitis C Virus NS5 Antigen, IgG Fraction, Monoclonal","description":"\u003cp\u003eMouse monoclonal antibody recognizing the NS5 antigen (Clone 2F6\/G11) spanning N2054-C2295 of the HCV (subtype 1a) sequence. It has been produced using highly purified NS-5 antigen.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e At least 1 year at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody is reactive in ELISA and dot blot tests. IgG Subtype: IgG-1.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 0.50 mg\/mL in 0.1M Tris-HCl (pH 7.5)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- AB_PUBLISHED_USE_START --\u003e\n\u003csection class=\"ab-published-use ab-published-use-complete\"\u003e\n\u003ch3 id=\"ab-published-use-hcm-131\"\u003ePublications using Austral Biologicals HCM-131-5\u003c\/h3\u003e\n\u003cp\u003eThe following scientific publications report use of Austral Biologicals HCM-131-5:\u003c\/p\u003e\n\u003col class=\"ab-publication-list ab-publication-list-complete\"\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1016\/j.jbc.2024.107286\" rel=\"noopener\" target=\"_blank\"\u003eProximity labeling of host factor ANXA3 in HCV infection reveals a novel LARP1 function in viral entry\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eBley et al., J Biol Chem 300(5):107286 (2024).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.ppat.1009496\" rel=\"noopener\" target=\"_blank\"\u003eHepatitis C virus infection restricts human LINE-1 retrotransposition in hepatoma cells\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSchöbel et al., PLoS Pathog 17(4):e1009496 (2021).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.02009-18\" rel=\"noopener\" target=\"_blank\"\u003eDehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus, Is a New Inhibitor of Hepatitis C Virus RNA Replication\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSahuc et al., J Virol 93(10):e02009-18 (2019).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.01997-17\" rel=\"noopener\" target=\"_blank\"\u003eRoles of the 5' Untranslated Region of Nonprimate Hepacivirus in Translation Initiation and Viral Replication\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTanaka et al., J Virol 92(7):e01997-17 (2018).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.00355-17\" rel=\"noopener\" target=\"_blank\"\u003eHepatitis C Virus Subverts Human Choline Kinase-α To Bridge Phosphatidylinositol-4-Kinase IIIα (PI4KIIIα) and NS5A and Upregulates PI4KIIIα Activation, Thereby Promoting the Translocation of the Ternary Complex to the Endoplasmic Reticulum for Viral Replication\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eWong MT and Chen SS, J Virol 91(16):e00355-17 (2017).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.ppat.1006374\" rel=\"noopener\" target=\"_blank\"\u003eCharacterization of miR-122-independent propagation of HCV\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eOno et al., PLoS Pathog 13(5):e1006374 (2017).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/srep41452\" rel=\"noopener\" target=\"_blank\"\u003eRNA helicase DDX3 maintains lipid homeostasis through upregulation of the microsomal triglyceride transfer protein by interacting with HNF4 and SHP\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTsai et al., Sci Rep 7:41452 (2017).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.18632\/oncotarget.12144\" rel=\"noopener\" target=\"_blank\"\u003eSmall heterodimer partner 1 directly interacts with NS5A viral protein and has a key role in HCV related liver cell transformation\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eConti et al., Oncotarget 7(51):84575-84586 (2016).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.01615-16\" rel=\"noopener\" target=\"_blank\"\u003eHepatitis C Virus Is Released via a Noncanonical Secretory Route\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eBayer et al., J Virol 90(23):10558-10573 (2016).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.00960-16\" rel=\"noopener\" target=\"_blank\"\u003eHuman Choline Kinase-α Promotes Hepatitis C Virus RNA Replication through Modulation of Membranous Viral Replication Complex Formation\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eWong MT and Chen SS, J Virol 90(20):9075-9095 (2016).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.00404-16\" rel=\"noopener\" target=\"_blank\"\u003eIdentification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eVausselin et al., J Virol 90(19):8422-8434 (2016).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/ncomms12203\" rel=\"noopener\" target=\"_blank\"\u003eSeptin 9 induces lipid droplets growth by a phosphatidylinositol-5-phosphate and microtubule-dependent mechanism hijacked by HCV\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eAkil et al., Nat Commun 7:12203 (2016).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0155708\" rel=\"noopener\" target=\"_blank\"\u003eHCV-Mediated Apoptosis of Hepatocytes in Culture and Viral Pathogenesis\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSilberstein et al., PLoS One 11(6):e0155708 (2016).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0148711\" rel=\"noopener\" target=\"_blank\"\u003eHepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eStindt et al., PLoS One 11(2):e0148711 (2016).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0142539\" rel=\"noopener\" target=\"_blank\"\u003eClaudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eFénéant et al., PLoS One 10(11):e0142539 (2015).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.01513-15\" rel=\"noopener\" target=\"_blank\"\u003eY-Box Binding Protein 1 Stabilizes Hepatitis C Virus NS5A via Phosphorylation-Mediated Interaction with NS5A To Regulate Viral Propagation\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eWang et al., J Virol 89(22):11584-11602 (2015).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.00192-15\" rel=\"noopener\" target=\"_blank\"\u003eNew Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eFénéant et al., J Virol 89(16):8346-8364 (2015).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/aac.03293-14\" rel=\"noopener\" target=\"_blank\"\u003eNS5A inhibitors impair NS5A-phosphatidylinositol 4-kinase IIIα complex formation and cause a decrease of phosphatidylinositol 4-phosphate and cholesterol levels in hepatitis C virus-associated membranes\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eReghellin et al., Antimicrob Agents Chemother 58(12):7128-7140 (2014).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0102511\" rel=\"noopener\" target=\"_blank\"\u003eVisualization and analysis of hepatitis C virus structural proteins at lipid droplets by super-resolution microscopy\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eEggert et al., PLoS One 9(7):e102511 (2014).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0099022\" rel=\"noopener\" target=\"_blank\"\u003eNonstructural protein 5A is incorporated into hepatitis C virus low-density particle through interaction with core protein and microtubules during intracellular transport\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eLai et al., PLoS One 9(6):e99022 (2014).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1074\/mcp.m113.036301\" rel=\"noopener\" target=\"_blank\"\u003eThe intraviral protein interaction network of hepatitis C virus\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eHagen et al., Mol Cell Proteomics 13(7):1676-1689 (2014).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0092343\" rel=\"noopener\" target=\"_blank\"\u003eLymphocytes as liver damage mirror of HCV related adipogenesis deregulation\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eMinutolo et al., PLoS One 9(3):e92343 (2014).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.03839-13\" rel=\"noopener\" target=\"_blank\"\u003eNovel permissive cell lines for complete propagation of hepatitis C virus\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eShiokawa et al., J Virol 88(10):5578-5594 (2014).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.03055-13\" rel=\"noopener\" target=\"_blank\"\u003eInnate immune response induced by baculovirus attenuates transgene expression in mammalian cells\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eOno et al., J Virol 88(4):2157-2167 (2014).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.ppat.1003775\" rel=\"noopener\" target=\"_blank\"\u003eSPOC1-mediated antiviral host cell response is antagonized early in human adenovirus type 5 infection\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSchreiner et al., PLoS Pathog 9(11):e1003775 (2013).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1002\/hep.26273\" rel=\"noopener\" target=\"_blank\"\u003eThe antimalarial ferroquine is an inhibitor of hepatitis C virus\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eVausselin et al., Hepatology 58(1):86-97 (2013).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.ppat.1003302\" rel=\"noopener\" target=\"_blank\"\u003eLipid droplet-binding protein TIP47 regulates hepatitis C Virus RNA replication through interaction with the viral NS5A protein\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eVogt et al., PLoS Pathog 9(4):e1003302 (2013).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1074\/jbc.m112.434910\" rel=\"noopener\" target=\"_blank\"\u003eDiacylglycerol acyltransferase-1 localizes hepatitis C virus NS5A protein to lipid droplets and enhances NS5A interaction with the viral capsid core\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eCamus et al., J Biol Chem 288(14):9915-9923 (2013).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1111\/cmi.12112\" rel=\"noopener\" target=\"_blank\"\u003eEWI-2wint promotes CD81 clustering that abrogates Hepatitis C Virus entry\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003ePotel et al., Cell Microbiol 15(7):1234-1252 (2013).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.00567-12\" rel=\"noopener\" target=\"_blank\"\u003eExpression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eFukuhara et al., J Virol 86(15):7918-7933 (2012).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.06327-11\" rel=\"noopener\" target=\"_blank\"\u003eAnnexin A2 is involved in the formation of hepatitis C virus replication complex on the lipid raft\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSaxena et al., J Virol 86(8):4139-4150 (2012).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.06001-11\" rel=\"noopener\" target=\"_blank\"\u003eProline-serine-threonine phosphatase-interacting protein 2 (PSTPIP2), a host membrane-deforming protein, is critical for membranous web formation in hepatitis C virus replication\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eChao et al., J Virol 86(3):1739-1749 (2012).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.06242-11\" rel=\"noopener\" target=\"_blank\"\u003eEstablishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eKambara et al., J Virol 86(3):1382-1393 (2012).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.06099-11\" rel=\"noopener\" target=\"_blank\"\u003eDysfunction of autophagy participates in vacuole formation and cell death in cells replicating hepatitis C virus\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTaguwa et al., J Virol 85(24):13185-13194 (2011).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0022808\" rel=\"noopener\" target=\"_blank\"\u003eGeneration of a cell culture-adapted hepatitis C virus with longer half life at physiological temperature\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eKim et al., PLoS One 6(8):e22808 (2011).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1074\/jbc.m111.220103\" rel=\"noopener\" target=\"_blank\"\u003eInteracting regions of CD81 and two of its partners, EWI-2 and EWI-2wint, and their effect on hepatitis C virus infection\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eMontpellier et al., J Biol Chem 286(16):13954-13965 (2011).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0015967\" rel=\"noopener\" target=\"_blank\"\u003eElimination of hepatitis C virus from hepatocytes by a selective activation of therapeutic molecules\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eWen et al., PLoS One 6(1):e15967 (2011).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1016\/j.virol.2010.10.026\" rel=\"noopener\" target=\"_blank\"\u003eChaperonin TRiC\/CCT participates in replication of hepatitis C virus genome via interaction with the viral NS5B protein\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eInoue et al., Virology 410(1):38-47 (2011).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1074\/jbc.m110.118323\" rel=\"noopener\" target=\"_blank\"\u003eHeat shock protein 72 is associated with the hepatitis C virus replicase complex and enhances viral RNA replication\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eChen et al., J Biol Chem 285(36):28183-28190 (2010).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.00068-10\" rel=\"noopener\" target=\"_blank\"\u003ePolo-like kinase 1 is involved in hepatitis C virus replication by hyperphosphorylating NS5A\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eChen et al., J Virol 84(16):7983-7993 (2010).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.ppat.1000910\" rel=\"noopener\" target=\"_blank\"\u003ePersistent growth of a human plasma-derived hepatitis C virus genotype 1b isolate in cell culture\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSilberstein et al., PLoS Pathog 6(5):e1000910 (2010).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.01190-09\" rel=\"noopener\" target=\"_blank\"\u003eIdentification of GBF1 as a cellular factor required for hepatitis C virus RNA replication\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eGoueslain et al., J Virol 84(2):773-787 (2010).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.4161\/auto.5.7.9243\" rel=\"noopener\" target=\"_blank\"\u003eKnockdown of autophagy-related gene decreases the production of infectious hepatitis C virus particles\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTanida et al., Autophagy 5(7):937-945 (2009).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.01035-09\" rel=\"noopener\" target=\"_blank\"\u003eCochaperone activity of human butyrate-induced transcript 1 facilitates hepatitis C virus replication through an Hsp90-dependent pathway\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTaguwa et al., J Virol 83(20):10427-10436 (2009).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.00308-09\" rel=\"noopener\" target=\"_blank\"\u003eNaturally occurring hepatitis C virus subgenomic deletion mutants replicate efficiently in Huh-7 cells and are trans-packaged in vitro to generate infectious defective particles\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003ePacini et al., J Virol 83(18):9079-9093 (2009).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.00889-09\" rel=\"noopener\" target=\"_blank\"\u003eHuman VAP-C negatively regulates hepatitis C virus propagation\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eKukihara et al., J Virol 83(16):7959-7969 (2009).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.00398-08\" rel=\"noopener\" target=\"_blank\"\u003eAssociation of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eLai et al., J Virol 82(17):8838-8848 (2008).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.ppat.1000035\" rel=\"noopener\" target=\"_blank\"\u003eEssential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eAppel et al., PLoS Pathog 4(3):e1000035 (2008).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.02253-07\" rel=\"noopener\" target=\"_blank\"\u003eA single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eOkamoto et al., J Virol 82(7):3480-3489 (2008).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.02153-07\" rel=\"noopener\" target=\"_blank\"\u003eHuman butyrate-induced transcript 1 interacts with hepatitis C virus NS5A and regulates viral replication\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTaguwa et al., J Virol 82(6):2631-2641 (2008).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.2353\/ajpath.2007.070413\" rel=\"noopener\" target=\"_blank\"\u003eResponses of nontransformed human hepatocytes to conditional expression of full-length hepatitis C virus open reading frame\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTang et al., Am J Pathol 171(6):1831-1846 (2007).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.00649-07\" rel=\"noopener\" target=\"_blank\"\u003eHepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eAbe et al., J Virol 81(17):8953-8966 (2007).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.02824-06\" rel=\"noopener\" target=\"_blank\"\u003eMonitoring the antiviral effect of alpha interferon on individual cells\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eKim et al., J Virol 81(16):8814-8820 (2007).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/sj.emboj.7601367\" rel=\"noopener\" target=\"_blank\"\u003eHepatitis C virus RNA replication is regulated by FKBP8 and Hsp90\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eOkamoto et al., EMBO J 25(20):5015-5025 (2006).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.75.13.6095-6106.2001\" rel=\"noopener\" target=\"_blank\"\u003eHepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003ePolyak et al., J Virol 75(13):6095-6106 (2001).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/section\u003e\n\u003c!-- AB_PUBLISHED_USE_END --\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_HCM-131_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"100 µg","offer_id":52518875988270,"sku":"HCM-131-5","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-hcm-131-100ug.png?v=1788008520","url":"https:\/\/www.australbiologicals.com\/products\/hcm-131","provider":"Austral Biologicals","version":"1.0","type":"link"}